SCHEMBL10089883

SCHEMBL10089883

Cc1cc(Cl)cc(C(=O)NCc2ccccc2C(F)(F)F)c1NC(=O)c1cc(Cn2nnc(C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.36
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
EPHX2 P34913 3/20 0.35
PTGES O14684 4/20 0.35
PPARG P37231 1/20 0.35
GRK2 P25098 2/20 0.34
GRK3 P35626 2/20 0.34
ROCK2 O75116 1/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCA P17252 1/20 0.34
PRKCH P24723 1/20 0.34
GRK5 P34947 1/20 0.34
PRKCI P41743 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10089841 0.95 TP53 (0.38) P2RX7TP53MEN1CYP1A2HPGD
SCHEMBL10089948 0.95 TP53 (0.35) P2RX7PPARGTP53MEN1KMT2A
SCHEMBL10089873 0.94 MAPK8 (0.36) P2RX7TP53NTRK1
SCHEMBL10089888 0.93 TP53 (0.34) P2RX7TP53MEN1KMT2A
SCHEMBL10090015 0.92 CARM1 (0.37) MEN1KMT2A
SCHEMBL10089867 0.92 TP53 (0.33) P2RX7EPHX2TP53MEN1HPGD
SCHEMBL10089973 0.92 P2RX7 (0.36) P2RX7EPHX2TP53HPGD
SCHEMBL10089967 0.92 DHODH (0.36) PPARGNTRK1
SCHEMBL10089937 0.91 HSD17B13 (0.40) EPHX2HSD17B13MAPK1
SCHEMBL10089870 0.91 KMT2A (0.36) PPARGKMT2ANTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 P2RX7 1165/4885MAPK13 3630/4885MAPK12 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.